The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1)
- Resource Type
- Article
- Source
- In
Chest January 2020 157(1):111-118 - Subject
- Language
- ISSN
- 0012-3692